Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

NCT04291729 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Ganovo+ritonavir+/-Interferon nebulization

Sponsor

The Ninth Hospital of Nanchang

Collaborators

[object Object]